AzTrials
AzTrials

Erector Spinae Plane BlockNCT05170373

ESP Block in Radical Prostatectomy

A study testing ESP block in people with Erector Spinae Plane Block, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Our study aimed to examine the effects of ultrasound guided erector spinae plane block in radical prostatectomy surgery on pain and surgical stress response, to reduce adrenocortical and sympathetic discharge due to anesthesia and surgery, and to reduce peroperative opioid analgesic consumption. Read more about this study

Who is it for?
Ages 30 to 74 years, men only
Conditions the study is for
Erector Spinae Plane Block
What is being tested?
ESP block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Feb 2019to 1 Jun 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 74 years
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ASA I-II

Who cannot join

  • diabetes
  • coagulopathy
  • local anesthetic
  • drug allergy
  • long hospitalization history,
  • hormone disorder
Show all 10Show fewer
  • advanced organ failure
  • history of steroid use
  • vertebral anomalies
  • mental retardation

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul Suleyman Yalcin City Hospital

    Istanbul

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of Ultrasound Guided Erector Spinae Plane Block in Radical Prostatectomy Surgery on Pain and Surgical Stress Response

Our study aimed to examine the effects of ultrasound guided erector spinae plane block in radical prostatectomy surgery on pain and surgical stress response, to reduce adrenocortical and sympathetic discharge due to anesthesia and surgery, and to reduce peroperative opioid analgesic consumption.

Read the detailed description

In this study 46 patients between the ages of 30-74, American Society of Anesthesiologists (ASA) score I-II and undergoing radical prostatectomy surgery at T.R. Ministry Of Health İstanbul Göztepe Prof. Dr. Süleyman Yalçın City Hospital were included. The patients were randomly divided into two groups as ESPB applied Group B (n=23) and not Group K (n=23). Patient-controlled analgesia (PCA) was initiated in all patients for postoperative analgesia. Patients' demographic data (age, gender, ASA score), intraoperative hemodynamic data, intraoperative and postoperative additional narcotic consumption, postoperative Numeric Rating Scale (NRS) scores (postoperative 0, 5 and 20 minutes and Then, 1, 3, 6, 12, 18 and 24 h), postoperative nausea-vomiting scores and possible complications related to block and / or surgery were recorded.Intraoperative MAP, HR, SpO2, BIS values of patients in both groups were recorded every 5 minutes. Blood glucose, insulin, cortisol, prolactin and C-reactive protein (CRP) were studied three times; preop morning at 6:00, intraoperative when surgical incision closing and postoperative 24h. in order to evaluate the surgical stress response in the patients.

Being tested
ESP block
Keywords
Erektor Spinae Plane Block, Postoperative Analgesia, Surgical Stress Response

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ESP blockProcedure or surgery

    Before general anesthesia, ESP block was applied from the T12 vertebra level with 10 ml 0.5% bupivacaine HCL 5 ml 2% lidocaine HCL 5 ml 0.9% isotonic NaCl mixture

Study groups in NCT05170373
Study groupRoleWhat they receive
ESP groupActive comparatorNot described
Receives: Procedure: ESP block
control groupNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Numeric Pain Scale

    Between 1-10. 1: no pain, 10: worst possible pain

    Measured: postoperative 24 hours.

  2. Blood glucose

    mg /dL

    Measured: postoperative 24 hours.

  3. insulin

    µIU/mL

    Measured: postoperative 24 hours.

  4. cortisol

    µg/dL

    Measured: postoperative 24 hours.

  5. prolactin

    µg/L

    Measured: postoperative 24 hours.

  6. C-reactive protein

    mg/L

    Measured: postoperative 24 hours.

Secondary outcomes (1)
  1. Remifentanil Consumption Speed

    µg /kg/dk

    Measured: 3 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Dec 2021
  2. Study start1 Feb 2019
  3. Primary completion1 Jun 2019
  4. Study completion1 Jun 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05170373
Sponsor's protocol ID
IstanbulMU ESPB
Status last verified
Dec 2021
First submitted
3 Nov 2021
Last updated
28 Dec 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing ESP block in people with Erector Spinae Plane Block, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Dec 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Numeric Pain Scale (time frame: postoperative 24 hours.). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Dec 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in